Testing allergy gene before gout treatment
Treatments studied
Part of Bones, joints & muscles, Genetic & congenital, Hormones & metabolism, Immune system & allergy, Mouth & dental, Skin clinical trials.
This trial checks if testing for a specific gene (HLA-B*58:01) before starting gout medication can prevent severe allergic reactions. It compares standard care with a gene-guided approach to see which is safer and works better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have gout and need to start a medication to lower uric acid levels.
- You have never taken allopurinol before.
- You can attend follow-up visits over one year.
- You are willing to have a blood test for gene testing and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new tablet called BR2251 for people with gout and high uric acid. It aims to lower uric acid levels and manage gout symptoms.
This trial tests a new tablet (HR091506) for adults with gout and high uric acid. It aims to lower uric acid levels and reduce gout attacks, especially for people with more severe gout (like tophi or frequent attacks).
This study compares two different treatment goals for a blood level called urate in people with gout. The goal is to see which approach lowers gout flares better while helping people feel better.
This trial tests whether people with well-controlled gout can safely stop their urate-lowering medication (allopurinol or febuxostat) if an ultrasound shows no urate crystals in their joints. It may help you avoid unnecessary medication while keeping your gout under control.
This trial tests a new medicine called tigulixostat against febuxostat, a standard gout treatment, to see which works better at lowering uric acid levels. You may qualify if you have gout with high uric acid and have not had a gout flare in the last month.
This study tests if a new drug, ABP-671, can safely lower high uric acid levels in people with chronic kidney disease. It may help reduce gout attacks and kidney damage.
Hear when a new Gout Initiating Urate-loweringUrate-lowering Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.